MD Anderson Cancer Center

Psilocybin research and therapeutic outcomes

5 clusters · 22 sources · last updated 5 days ago

Latest: Psilocybin may prevent chemotherapy-induced nerve damage

Research into psilocybin has transitioned from exploring microdosing protocols to evaluating structured, state-regulated therapeutic programs. Initial reports focused on microdosing guides, though clinical evidence remai

Cancer immunotherapy research and challenges

2 clusters · 7 sources · last updated 10 days ago

Latest: Cancer immunotherapy research highlights vaccine effects and treatment timing

Recent research into cancer immunotherapy has focused on understanding side effects, treatment timing, and the influence of other vaccines on patient outcomes. Initial studies identified that inflammatory arthritis caus

Research on rapid-acting antidepressant mechanisms

2 clusters · 2 sources · last updated 19 days ago

Latest: Ketamine may rapidly ease suicidal thoughts and improve cognition

Recent medical research has focused on the mechanisms and clinical benefits of rapid-acting antidepressants, particularly ketamine. Researchers at MD Anderson Cancer Center identified shared neuroimmune pathways activa

Advancements in MYC cancer protein research

2 clusters · 3 sources · last updated 21 days ago

Latest: MD Anderson researchers develop therapy targeting undruggable MYC protein

Recent medical research has focused on addressing the MYC protein, a master regulator of cell growth whose deregulation is linked to a majority of human cancers. Because the protein lacks traditional binding pockets, it

Advancements in gut microbiome research

2 clusters · 4 sources · last updated 24 days ago

Latest: Gut microbiota research advances intestinal repair and ulcerative colitis treatments

Scientific research into the gut microbiome is advancing new methods for managing intestinal health and disease. Initial developments focused on enhancing the protective capabilities of probiotics against Salmonella thro